MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.550
-0.020 (-1.27%)
At close: Jan 13, 2026, 4:00 PM EST
1.550
0.00 (0.00%)
Pre-market: Jan 14, 2026, 7:00 AM EST
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,718,411
Market Cap
59.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -5 | -27.78% |
| Dec 31, 2022 | 18 | 9 | 100.00% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MAIA News
- 20 days ago - MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings - GlobeNewsWire
- 4 weeks ago - MAIA Biotechnology Announces $1.51 Million Private Placement - GlobeNewsWire
- 4 weeks ago - MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates - GlobeNewsWire
- 4 weeks ago - MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - GlobeNewsWire
- 6 weeks ago - MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - GlobeNewsWire
- 7 weeks ago - MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025 - GlobeNewsWire
- 2 months ago - Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) - GlobeNewsWire
- 2 months ago - MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire